Result: 15% (3/20), p = 0.01)] found in
HBeAg positive patients whereas
A1762T/
G1764A with
A1053G in
enhancer-I region [54% (7/13) vs.
Result: Although the prevalence of
A1053G was extremely high in both
LC (50%) and
HCC (50%), it was only 6% in nLF and 11% in LF (p = 0.081) whereas,
T1050G/A and their combination
T1050G/A+
A1053G showed significant escalating trend over the course of infection from nLF (18%, 0%) to
HCC (54%, 32%) through LF (22%, 11%) and
PMID: 22014121
2011
BMC cancer